Illumina Inc (NASDAQ:ILMN) faces challenges from macroeconomic factors and competitive pressures, especially in China. Their 10-Q report for YTD 2024 shows decreased revenue, improved gross margins, operational losses due to impairment charges, and a decline in instrument shipments.